Exelixis Inc Inventory, Finished Goods, Net of Reserves
Exelixis Inc (EXEL) had Inventory, Finished Goods, Net of Reserves of $588.00 thousand as of 2014-09-30, per its 10-Q filed 2014-11-04.
Discontinued › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2014-11-04
- 2014-09-30: Inventory, Finished Goods, Net of Reserves $588.00K.
- 2014-06-30: Inventory, Finished Goods, Net of Reserves $512.00K.
- 2014-03-31: Inventory, Finished Goods, Net of Reserves $343.00K.
- 2013-12-31: Inventory, Finished Goods, Net of Reserves $81.00K.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2014-09-30 | $588.00K 10-Q · filed 2014-11-04 |
| 2014-06-30 | $512.00K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $343.00K 10-Q · filed 2014-05-01 |
| 2013-12-31 | $81.00K 10-Q · filed 2014-11-04 |
| 2013-09-30 | $89.00K 10-Q · filed 2013-10-30 |
| 2013-06-30 | $69.00K 10-Q · filed 2013-08-06 |
| 2012-12-31 | $0.00 10-Q · filed 2013-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |